Iffiltra skont
Blood, tissues, cells and organs - Key documents (148)
RSS2022 VES annual report - Vigilance Expert Subgroup (VES) of the National Competent Authorities (NCA) for Substances of Human Origin Expert Group
2022 VES annual report - Vigilance Expert Subgroup (VES) of the National Competent Authorities (NCA) for Substances of Human Origin Expert Group
2022 RAB and RATC annual summary of activity
2022 RAB and RATC annual summary of activity
Report on the implementation of Directive 2010/53/EU on standards of quality and safety of human organs intended for transplantation
Report on the implementation of Directive 2010/53/EU on standards of quality and safety of human organs intended for transplantation
COM(2022) 338 final
COM(2022) 338 final
2021 RAB and RATC annual summary of activity
2021 RAB and RATC annual summary of activity
2021 VES annual report - Vigilance Expert Subgroup (VES) of the National Competent Authorities (NCA) for Substances of Human Origin Expert Group
2021 VES annual report - Vigilance Expert Subgroup (VES) of the National Competent Authorities (NCA) for Substances of Human Origin Expert Group
Summary of the 2020 annual reporting of serious adverse reactions and events for blood and blood components
Summary of the 2020 annual reporting of serious adverse reactions and events for blood and blood components
Summary of the 2020 annual reporting of serious adverse reactions and events for tissues and cells
Summary of the 2020 annual reporting of serious adverse reactions and events for tissues and cells
2020 RAB and RATC annual summary of activity
2020 RAB and RATC annual summary of activity
Summary of the 2019 annual reporting of serious adverse reactions and events for blood and blood components
Summary of the 2019 annual reporting of serious adverse reactions and events for blood and blood components
Summary of the 2019 annual reporting of serious adverse reactions and events for tissues and cells
Summary of the 2019 annual reporting of serious adverse reactions and events for tissues and cells
2019 RAB and RATC annual summary of activity
2019 RAB and RATC annual summary of activity
2019 RAB and RATC annual summary of activity
2019 RAB and RATC annual summary of activity
Summary of the 2018 annual reporting of serious adverse reactions and events for blood and blood components
Summary of the 2018 annual reporting of serious adverse reactions and events for blood and blood components
Summary of the 2018 annual reporting of serious adverse reactions and events for tissues and cells
Summary of the 2018 annual reporting of serious adverse reactions and events for tissues and cells
Evaluation of the EU blood and tissues and cells legislation
Evaluation of the EU blood and tissues and cells legislation
Common approach document for definition of reportable serious adverse events and reactions
Common approach document for definition of reportable serious adverse events and reactions
2018 RAB and RATC annual summary of activity
2018 RAB and RATC annual summary of activity
Summary of the 2017 annual reporting of serious adverse reactions and events for blood and blood components
Summary of the 2017 annual reporting of serious adverse reactions and events for blood and blood components